
    
      The trial consists of three cohorts

        1. Symptomatic HOCM patients with severe LVOT obstruction undergoing PTSMA (reference
           group)

        2. Asymptomatic HOCM patients with severe LVOT obstruction undergoing PTSMA (study group)

        3. Asymptomatic HOCM patients with severe LVOT obstruction with no intervention
           (observation group)
    
  